Answers are grounded in this paper and cite their sources.
1.33; 95% CI 0.7-2.5) were not increased in triptan-exposed pregnancies. Conclusions Our findings support the evidence that triptans are not major teratogens. When compellingly needed during pregnancy, sumatriptan as the best studied triptan appears an acceptable treatment option. A detailed fetal ultrasound should be offered in cases of first trimester exposure to less well-studied triptans. Trial registration number in German Clinical Trials Register: DRKS00007660.
No takes yet. Share an insight, caveat, or question.
Spielmann et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: